In conclusion, the conversion of bile acids mediated by the microbiota is pivotal in maintaining glucose homeostasis, lipid metabolism, and energy balance through the FXR and TGR5 signaling pathways, offering novel insights and targets for the treatment of metabolic diseases [324]. This evidence concerns the gene GPBAR1 and metabolic disease.